Reverse-Cyte 0.8%
Multiple blood grouping ABO - human origin · class IV · Until 25/11/2029
- Registration no.
- 80134860269
- Process no.
- 25351388668201937
- Status
- Until 25/11/2029
- Device type
- Multiple blood grouping ABO - human origin (TIPAGEM SANGUÍNEA MÚLTIPLA ABO - ORIGEM HUMANA)
- Risk class
- IV
- Registration holder
- GRIFOLS BRASIL LTDA CNPJ 02.513.899/0001-71 · 342 registrations
- Manufacturer
- Published
- 25/11/2019
- Valid until
- 25/11/2029
- Last updated by ANVISA
- 2026-10-12
- Official record
- View on ANVISA ↗
Other multiple blood grouping abo - human origin registrations (5 in total, see all)
| Product | Class | Holder | Published | Status |
|---|---|---|---|---|
| Família Reverse-Cyte® 5%
80134860273 |
IV | GRIFOLS BRASIL LTDA | 28/12/2020 | Until 28/12/2030 |
| SERIGRUP DIANA A2
80134860105 |
IV | GRIFOLS BRASIL LTDA | 23/04/2007 | Until 23/04/2027 |
| SERIGRUP DIANA 4
80134860102 |
IV | GRIFOLS BRASIL LTDA | 09/04/2007 | Until 09/04/2027 |
| SERIGRUP DIANA A1/B
80134860084 |
IV | GRIFOLS BRASIL LTDA | 28/12/2004 | Until 28/12/2034 |